| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.1M | +0.3% |
| Cost of Revenue | $1.2M | -8.0% |
| R&D Expense | $2.0M | +99.6% |
| SG&A Expense | $3.8M | -3.6% |
| Operating Income | -$4.9M | -8.9% |
| Interest Expense | $76K | +814.6% |
| Pre-tax Income | -$5.5M | -22.3% |
| Net Income | -$5.5M | -22.3% |
| EPS (Basic) | -$0.69 |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $493K | -75.2% |
| Accounts Receivable | $149K | +31.5% |
| Inventory | $169K | -26.5% |
| Current Assets | $1.0M | -62.1% |
| Total Assets | $7.5M | -20.5% |
| Current Liabilities | $999K | +33.5% |
| Total Liabilities | $1.1M | +22.1% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | -18.1% |
| Capital Expenditures | $52K | -34.7% |
| Investing Cash Flow | -$52K | +34.7% |
| Financing Cash Flow | $2.1M | +1203.6% |
| Free Cash Flow | -$3.6M | -16.7% |
| -30.2% |
| EPS (Diluted) | -$0.69 | -30.2% |
| Stockholders' Equity |
| $6.4M |
| -24.9% |